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AbstrAct
Objective We estimated associations of time of day with 
cardiovascular disease (CVD) risk factors measured in 
older men.
Methods CVD risk factors (markers of inflammation and 
haemostasis, and cardiac markers) were measured on 
one occasion between 08:00 and 19:00 hours in 4252 
men aged 60–79 years from the British Regional Heart 
Study. Linear models were used to estimate associations 
between time of day and risk factors. When an association 
was found, we examined whether the relationship between 
risk factors and cardiovascular mortality was affected by 
the adjustment for time of day using survival analyses.
results N-terminal pro-brain natriuretic peptide (NT-
proBNP) levels increased by 3.3% per hour (95% CI 1.9% 
to 4.8%), interleukin-6 (IL-6) increased by 2.6% per hour 
(95% CI 1.8% to 3.4%), while tissue plasminogen activator 
(t-PA) decreased by 3.3% per hour (95% CI 3.7% to 2.9%); 
these associations were unaffected by adjustment for 
possible confounding factors. The percentages of variation 
in these risk factors attributable to time of day were less 
than 2%. In survival analyses, the association of IL-6, 
NT-proBNP and t-PA with cardiovascular mortality was 
not affected by the adjustment for time of day. C reactive 
protein, fibrinogen, D-dimer, von Willebrand factor and 
cardiac troponin T showed no associations with time of 
day.
conclusions In older men, markers of inflammation (IL-
6), haemostasis (t-PA) and a cardiac marker (NT-proBNP) 
varied by time of day. The contribution of time of day to 
variations in these markers was small and did not appear 
to be relevant for the CVD risk prediction.
bAckgrOund
Previous studies have reported time of day 
variation in both established and emerging 
cardiovascular disease (CVD) risk factors in 
middle-aged adults, such as blood pressure, 
lipids and some well-established inflam-
matory and haemostatic factors (eg, white 
cell, red blood cell and platelet counts).1–3 
However, the extent to which some emerging 
CVD risk factors such as interleukin (IL)-6 , 
a marker of inflammation causally associated 
with CHD in a recent study,4 and N-terminal 
pro-brain natriuretic peptide (NT-proBNP), a 
marker of heart failure,5 vary by time of day 
have been less studied. Moreover, very little 
is known on time of day variations in other 
emerging risk factors prospectively associated 
with CVD (eg, tissue plasminogen activator 
(t-PA), D-dimer, von Willebrand factor (vWF) 
and cardiac troponin T (cTnT)), although 
their causal association with CVD remain 
debated or not yet tested.
We would expect that time of day variations 
in some emerging CVD risk factors measured 
in older adults may occur, consistent with 
findings in younger populations.6 However, 
in older adults, the degree of difference 
attributable to time of day has not been yet 
estimated; establishing its importance and its 
effects on prediction of CVD risk is important 
given the potentially wider use of NT-proBNP 
in risk stratification (as shown in a recent 
major meta-analysis in the general popula-
tion7) and potential causal link between IL-6 
and CVD.4 Therefore, the aim of this study 
was to investigate how emerging CVD risk 
factors, including markers of inflammation, 
haemostasis and myocardial function, varied 
by time of day in older British men.
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Research
strengths and limitations of this study
 ► To our knowledge, this is the largest investigation of 
relationships between time of day and cardiovascular 
disease (CVD) risk factors in older men.
 ► This study assessed the contribution of time of the 
day to the overall variation of CVD risk factors, and 
established its relevance for the CVD prediction.
 ► The relationship of the CVD risk factors to time 
of day was explored using between-participant 
variation only.
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MethOds
Participants
The British Regional Heart Study (BRHS) is a prospec-
tive cohort study of CVD involving 7735 middle-aged men 
(40–59 years) selected in 1978–1980 from the age–sex 
registers of one local primary care centre in 24 British 
towns.8 The 24 towns were selected to represent the 
variation in CVD across the UK.9 Participants provided 
informed written consent to the investigation, which 
was performed in accordance with the Declaration of 
Helsinki.10
Follow-up examination
In 1998–2000, an average of 20 years after the initial 
recruitment, 4252 surviving participants (77% response 
rate) aged 60–79 years who were resident in the UK 
attended a physical examination during which nurses 
took a fasting blood sample on one occasion for each 
participant. The men were asked to fast for a minimum of 
6 hours, during which they were instructed to drink only 
water, as previously reported.2 The blood samples were 
collected between 08:00 and 19:00 hours and then assayed 
for a range of biochemical and haematological markers. 
Participants’ appointment times were non-systematically 
allocated. They were offered the opportunity to contact 
the BRHS team and change the time of examination if 
unable to attend; a small proportion of participants did 
so.
The participants were also asked to complete a ques-
tionnaire that included questions on other established 
CVD risk factors, such as age, social class, smoking 
habits, alcohol consumption and physical activity. Specif-
ically, physical activity levels were self-reported11 and 
recently validated using accelerometers.12 Incident CVDs, 
including non-fatal stroke and non-fatal myocardial 
infarction (MI), were recorded: their definitions have 
been reported elsewhere.13 Men were also asked whether 
a doctor had ever told them that they had heart failure.5 
The number of blood samples collected and included in 
the analyses differ according to the risk factor measure-
ments (the number of observations varied from 3580 for 
NT-proBNP to 3863 for von Willebrand Factor in complete 
case analyses including all covariates of interest).
cVd risk factors
Circulating levels of markers of inflammation (C reactive 
protein (CRP), IL-6 and fibrinogen), cardiac markers 
(NT-proBNP and cTnT) and markers of haemostasis 
(t-PA antigen, fibrin D-dimer and vWF) were measured.
D-dimer and t-PA levels were measured using an ELISA 
(Biopool AB, Umeå, Sweden), as was vWF antigen (Dako, 
High Wycombe, UK). CRP was assayed using ultrasensi-
tive nephelometry (Dade Behring, Milton Keynes, UK). 
IL-6 was assayed using a high-sensitivity ELISA (R&D 
Systems, Oxford, UK). Fibrinogen was assayed using an 
automated Clauss assay in a coagulometer (MDA-180, 
Organon Teknika, Cambridge, UK). NT-proBNP and 
cTnT were measured in plasma samples on an automated 
clinically validated immunoassay analyser (e411, Roche 
Diagnostics, Burgess Hill, UK) using the manufacturers’ 
calibrators and quality control reagents. Intra-assay and 
interassay coefficient of variations were respectively: 4.1% 
and 6.6% for t-PA; 3.2% and 4.2% for vWF; 4.7% and 5.2% 
for D-dimer; 4.7% and 8.3% for CRP; 7.5% and 8.9% for 
IL-6; 2.6% and 3.7% for fibrinogen and 4.4% and 7.7% 
for NT-proBNP and cTnT.
The samples were centrifuged and separated on the 
morning or afternoon of collection and stored on site 
at −20°C until they were transferred to a central freezer 
storage location at −70°C within 2 weeks of sample collec-
tion. Samples were then transferred on dry ice to a single 
central laboratory and were thawed immediately before 
analysis. Plasma samples were used for all the analyses 
reported here. The original sample collection took place 
between January 1998 and March 2000. Most of the anal-
yses described here were carried out during 2000, after a 
maximum of 3 years storage; NT-proBNP and cTNT were 
analysed in 2009.
statistical methods
First, the distributions of the outcomes were examined; 
the outcomes were log-transformed as the distributions 
were positively skewed. Therefore, analysis was carried 
out on their log-transformed values throughout. Unad-
justed geometric means and 95% CIs of the outcomes 
were plotted against hour of the day.
Adjusted associations between time of day and the outcomes
Associations between time of day (fitted as a continuous 
variable, range 8–18) and the outcomes were examined 
using linear multilevel random intercept models (level 
1=individual, level 2=town of residence). The results 
can be interpreted as between-person variations over 
the course of the examination day; the estimates from 
the linear model were reported as the difference in the 
outcome levels per hour of sampling over the examination 
day. As the outcomes were log-transformed, the results 
were reported as per cent difference in the outcome 
geometric mean per hour of sampling. All models were 
initially adjusted for age only. Next, the models were 
adjusted for age and other possible confounding factors: 
social class, body mass index, previous stroke or MI, phys-
ical activity, smoking status, alcohol consumption, use of 
statin and a seasonal term (fitted using a cosinor func-
tion, as in previous studies).14 As NT-proBNP and cTnT 
are principally markers of heart failure, the association 
with time of day was adjusted for previous heart failure.
When the association of time of the day with the 
outcomes was found to be statistically significant, the 
proportion of variance associated with time of the day was 
estimated using partial R2.
Sensitivity analyses
Six sensitivity analyses were performed: (1) all models 
were additionally adjusted for fasting time and diabetes; 
(2) all models were carried out excluding men with 
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Table 1 Individual characteristics and risk factor levels in 
the British Regional Heart Study of men who have attended 
the examination in 1998–2000
Demographic and background characteristics
Age (years), mean (SD) 68.7 (5.5)
Social class (manual)
  Manual, n (%) 2166 (51.1)
  Non-manual, n (%) 1966 (46.3)
  Armed Forces, n (%) 112 (2.6)
Physical health
  Body mass index, mean (SD) 26.9 (3.7)
  Prevalence of stroke/myocardial infarction, n (%) 153 (3.6)
  Prevalence of heart failure, n (%) 390 (9.2)
  Diabetes, n (%) 478 (11.2)
Behavioural factors
  Smoking
  Never, n (%) 1233 (29.1)
  Ex-smokers, n (%) 2464 (58.0)
  Smokers, n (%) 548 (12.9)
Alcohol consumption
  None, n (%) 431 (10.3)
  Occasional/light, n (%)* 2949 (70.5)
  Moderate/heavy, n (%)† 779 (18.6)
Physical activity level
  Inactive, n (%) 471 (11.5)
  Occasionally, n (%) 957 (23.4)
  Light, n (%) 767 (18.7)
  Moderate, n (%) 591 (14.4)
  Moderate vigorous, n (%) 690 (16.8)
  Vigorous, n (%) 621 (15.1)
CVD risk factor, geometric mean (SD)
  CRP, mg/L 1.74 (3.03)
  IL-6, pg/mL 2.46 (1.94)
  Fibrinogen, g/L 3.19 (1.25)
  t-PA, ng/mL 10.23 (1.50)
  vWF, IU/dL 132.41 (1.40)
  D-dimer, ng/mL 84.32 (2.32)
  NT-proBNP, pg/mL 101.50 (3.32)
  cTnT, pg/mL 12.07 (1.64)
*≥1 and ≤15 units per week (1 unit is approximately one drink, such 
as one glass of wine).
†≥16 units per week (1 unit is approximately one drink, such as 
one glass of wine).
CRP, C reactive protein; cTnT, cardiac troponin T; IL-6, 
interleukin-6; NT-proBNP, N-terminal pro-brain natriuretic peptide; 
t-PA, tissue plasminogen activator; vWF, von Willebrand factor.
diabetes; (3) interactions were fitted to test whether the 
time of day associations were modified by age (fitted as 
continuous variable); (4) as NT-proBNP and cTnT were 
acknowledged as specific cardiac markers,5 interactions 
were fitted to test whether the time of day associations 
were modified by previous heart failure (yes/no); (5) 
to explore the potential of undiagnosed heart failure 
or cardiac damage influencing findings for NT-proBNP 
and cTnT, we repeated regression models after excluding 
men with NT-proBNP >400 pg/mL; and (6) a quadratic 
term for time of day was added to the models in order to 
check for non-linearity.
As IL-6 has been causally associated with cardiovascular 
risk,4 and prospectively associated with CVD mortality in 
the BRHS sample used here,15 we investigated the rele-
vance of time of day to the cardiovascular risk prediction 
by performing two survival analyses: in the first analysis, 
we used Cox models where unadjusted log IL-6 was used as 
the predictor and CVD mortality as the clinical outcome, 
then we repeated the same analysis using log IL-6 stan-
dardised by the time of day rather than unadjusted log 
IL-6. For completeness of information, we repeated this 
sensitivity analysis for NT-proBNP and t-PA.
results
The characteristics of the study participants (mean age 
68.7 years, SD=5.5) are reported in table 1. The associ-
ations between time of day (by hour) and risk factors 
are shown in figure 1. Evidence of an increase over the 
course of the day was particularly noticeable for IL-6 and 
for NT-proBNP (figure 1). Also, levels of t-PA were lower 
in the afternoon in comparison with morning, while 
variations by time of day for other risk factors were not 
clearly observable from the plots (figure 1). The results 
of corresponding linear regression analyses are shown in 
table 2; statistically significant associations between time 
of the day and some outcomes were found (table 2); over 
the course of the examination day, NT-proBNP levels 
increased by 3.3% per hour (95% CI 1.9% to 4.8%) and 
IL-6 increased by 2.6% per hour (95% CI 1.8% to 3.4%). 
Conversely, t-PA decreased by 3.3% per hour (95% CI 
3.7% to 2.9%). The proportion of variance associated with 
time of the day from the fully adjusted models was 0.5%, 
1%, and 2% for NT-proBNP, IL-6 and t-PA, respectively.
sensitivity analyses
Overall, we found that fasting time did not alter the 
magnitude of associations between time of the day and 
the outcomes reported in table 2. Only the association 
between time of the day and t-PA was strongly attenuated 
after accounting for fasting time (fitted as continuous 
variable): the decrease in t-PA levels was −3.3% (95% CI 
−3.7 to −2.9) per hour before the adjustment (table 2) 
and −1.4% (95% CI −2.2% to −0.1%) after the adjustment 
for fasting. An additional adjustment for diabetes status 
did not alter the magnitude of the association between 
hour of the day and the outcomes. We also performed the 
analysis excluding men with diabetes completely (table 2, 
model 3), but the association between time of day and the 
outcomes did not substantially change.
For all outcomes, we also did not find evidence for an 
interaction between of time of day with age (results not 
shown).
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Figure 1 Unadjsted geometric means (95% CI) by time of the day* for C reactive protein (CRP), interleukin-6 (IL-6), fibrinogen, 
tissue plasminogen activator (t-PA), von Willebrand factor (vWF), fibrin D-dimer, N-terminal pro-brain natriuretic peptide (NT-
proBNP) and cardiac troponin T (cTnT) measured on one occasion in BRHS men aged 60–79 during the years 1998–2000. *Total 
number of men examined per hour was 33 (0.7%) at 08:00–08:59, 363 (8.5%) at 8:00–9:59 hours, 699 (16%) at 10:00–
10:59 hours, 771 (18%) at 11:00–11:59 hours, 591 (14%) at 12:00–12:59 hours, 99 (2%) at 13:00–13:59 hours, 306 (7%) at 14:00–
14:59, 560 (13%) at 15:00–15:59 hours, 566 (13%) at 16:00–16:59, 260 (6%) at 17:00–17:59 and 3 (<0.1%) at 18:00–18:59.
In stratified analysis, NT-proBNP levels increased by 
3.4% (95% CI 1.9% to 4.8%, p<0.001) per hour in older 
men without heart failure. Although men who previously 
had heart failure had increased NT-proBNP levels, there 
was no evidence for an interaction between previous 
heart failure with time of the day (p=0.954). After 
excluding 466 men with NT-proBNP level of >400 pg/
mL (12% of the sample), associations between time of 
the day measures and NT-proBNP remained statistically 
significant and slightly increased in magnitude (3.9% 
(95% CI 2.7% to 5.1%), p<0.001). As reported in the 
main analysis, no significant associations were found 
between time of the day and cTnT in stratified analysis.
When adding a quadratic term to the model, we found 
a significant improvement in model fit for IL-6 only 
(p=0.030 for the time of day squared term). The asso-
ciation of time of day with IL-6 appeared to be slightly 
J-shaped, with a linear increase starting from 11:00 to 
19:00 hours.
We examined whether adjustment for hour of day 
affected the associations between risk factors and CVD 
mortality. In survival analysis, higher levels of log IL-6 were 
associated with increased CVD mortality (HR=1.70, 95% CI 
1.54 to 1.87). Standardising IL-6 by time of the day did not 
change the relationship (HR=1.71, 95% CI 1.55 to 1.88). 
Also, standardising NT-proBNP levels by time of the day 
did not alter the magnitude of the effect on CVD mortality 
(HR=1.92, 95% CI 1.81 to 2.04). Finally, associations of t-PA 
levels with increased CVD mortality did not change substan-
tially before (HR=1.74, 95% CI 1.45 to 2.09) and after stan-
dardising (HR=1.77, 95% CI 1.47 to 2.14) by time of the day.
discussiOn
To our knowledge, this is the largest investigation of rela-
tionships between time of day and CVD risk factors in older 
men. After adjusting our analysis for potential confounding 
factors, we demonstrated that some, but not all, CVD risk 
factors levels varied by time of day. In particular, NT-proBNP 
and IL-6 increased linearly over the course of the day. 
Conversely, a decrease in t-PA was also observed; however, 
after accounting for fasting time, the relationship with time 
of the day was strongly attenuated (therefore fasting time 
could partially explain the drop in t-PA levels observed in 
the afternoon vs morning). Our analyses showed that the 
contribution of time of the day to the overall variation of 
NT-proBNP, IL-6 and t-PA was small and without clinical 
importance; we observed that time of day did not have a 
sufficiently strong effect to be taken into account when 
assessing the impact of IL-6, NT-proBNP and t-PA on CVD 
mortality. Lastly, an association of time of day with other risk 
factors was not observed.
Literature on time of day variation in emerging CVD 
markers of inflammation and haemostasis in older adults 
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Table 2 Cross-sectional adjusted associations between time of day (fitted as continuous variable) and cardiovascular disease 
(CVD) risk factors measured in the British Regional Heart Study (BRHS) men (aged 60–79) attending the follow-up year 20 
examination in 1998–2000
CVD risk 
factor‡
Model 1: age adjusted* Model 2: fully adjusted†
Model 3: fully adjusted† excluding 
men with diabetes
Per cent difference 
(95% CI) in the CVD risk 
factor levels per hour of 
sampling§ p Value
Per cent difference 
(95% CI) in the CVD risk 
factor levels per hour of 
sampling§ p Value
Per cent difference 
(95% CI) in the CVD risk 
factor levels per hour of 
sampling p Value
NT-proBNP 3.5 (2.0 to 5.0) <0.001 3.3 (1.9 to 4.8) <0.001 3.5 (2.0  to 5.0) <0.001
IL-6 2.6 (1.7 to 3.4) <0.001 2.6 (1.8 to 3.4) <0.001 2.4 (1.6 to 3.3) <0.001
t-PA −3.3 (-3.8 to −2.9) <0.001 −3.3 (−3.7 to −2.9) <0.001 −3.2 (−3.6 to −2.7) <0.001
Fibrinogen −0.2 (−0.5 to 0.0) 0.088 −0.2 (−0.5 to 0.1) 0.104 −0.2 (−0.5 to 0.1) 0.149
cTnT −0.4 (−0.9 to 0.2) 0.194 −0.4 (−1.0 to 0.2) 0.174 −0.4 (−1.0 to 0.2) 0.165
CRP −1.0 (−2.3 to 0.4) 0.151 −0.9 (−2.2 to 0.4) 0.175 −0.9 (−2.2 to 0.5) 0.191
vWF −0.2 (−0.6 to 0.2) 0.374 −0.2 (−0.6 to 0.2) 0.380 −0.1 (−0.5 to 0.3) 0.703
D-dimer −0.0 (−1.0 to 1.0) 0.929 −0.1 (−1.0 to 0.9) 0.890 −0.1 (−1.2 to 0.9) 0.801
Associations are reported as per cent difference in CVD risk factors levels per 1 hour of sampling over the examination day (08:00–
19:00 hours). The statistically significant associations are marked in bold
*Model 1: two level linear models (level 1=person and level 2=town of residence during the BRHS recruitment) adjusted for age. Model 1 used 
the same number of observations of Model 2 (complete case analysis).
†Model 1 additionally adjusted for social class, body mass index, smoking status, alcohol consumption, physical activity, use of statin 
and season. Associations with IL-6, t-PA, fibrinogen, CRP, vWF and D-dimer were additionally adjusted for prevalence of stroke/MI, while 
association of time of the day with NT-proBNP and cTnT models were additionally adjusted for prevalence of heart failure.
‡Model 1 and Model 2 used the same number of observations: 3580 for NT-proBNP, 3832 for IL-6, 3863 for t-PA, 3861 for fibrinogen, 3827 for 
cTnT, 3838 for CRP, 3863 for vWF, 3859 for D-dimer.
§Model 3 number of observations: 3176 for NT-proBNP, 3398 for IL-6, 3429 for t-PA, 3427 for fibrinogen, 3398 for cTnT, 3405 for CRP, 3429 
for vWF, 3425 for D-dimer.
CRP, C reactive protein; cTnT, cardiac troponin T; IL-6, interleukin-6; MI, myocardial infarction; NT-proBNP, N-terminal pro-brain natriuretic 
peptide; t-PA, tissue plasminogen activator; vWF, von Willebrand factor.
is limited; to our knowledge, this is the first time these find-
ings have been reported in older adults. Findings from 
earlier studies of younger adults were fairly consistent with 
ours. For example, a recent meta-analysis of several small 
studies that analysed IL-6 proposed a diurnal pattern, with 
overall IL-6 levels increased between 08:00 and 19:00 hours 
as in our study.16 However, in two earlier very small studies 
of 1217 and 518 participants, IL-6 peaked in the night-time. 
It is possible that peaks in IL-6 levels may be associated with 
cognitive symptoms of depression19 and daily activities, 
although in the BRHS population, this has not yet been 
investigated. One previous study found that BRHS men 
were more active in the morning and in early afternoon20 
when the main activities were usually gardening, house 
works, shopping or leisure walking. Whether IL-6 was impli-
cated in this daily pattern remains uncertain and can poten-
tially be explored in future studies.
Moreover, one previous study reported increased levels of 
NT-ProBNP over the course of day21 as we observed in our 
study. A decrease in t-PA over the examination day was also 
reported in younger subjects (a 45-year-old UK population 
of 9377 men and women)6; however, t-PA did not vary by 
time of the day in a previous large study of 1288 healthy 
men and women aged 25–64 years.22
In comparison with our study, findings regarding CRP, 
fibrinogen, D-dimer, vWF and cTnT reported in earlier 
studies of younger adults were similar; a few previous studies 
reported that they did not find an association of time of day 
with CRP,23 D-dimer24 and vWF.25 In one study, the variation 
in CRP, fibrinogen, D-dimer and vWF attributable to time of 
day was minimal.6 Literature on cTnT is scarce; one small 
previous study of repeated measures in seven participants 
with type 2 diabetes reported a decrease in cTnT between 
08:00 and 20:00.26
Although one previous study suggested that diurnal 
variations in CVD risk factors could be relevant for cardio-
vascular risk prediction,6 a prediction model like the one 
described in our survival analysis was not performed. Our 
findings suggested the effect of time of the day (from 
08:00 hours to 19:00 hours) is not relevant for the CVD 
risk assessment. With this sensitivity analysis, we wanted to 
investigate time of day variations beyond simple descriptive 
diurnal patterns; to our knowledge, this is the first time this 
finding has been reported.
strengths and limitations
The BRHS cohort benefits from using a large-scale popu-
lation-based sample of free-living older men, and this 
increases statistical power and precision of estimates. 
However, the BRHS comprises male participants, predom-
inantly of white European ethnic origin, so findings may 
not be generalisable to women and non-white ethnic 
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groups. The CVD risk factors measurements were carried 
out on one occasion over an extended period of the day 
(between 08:00 and 19:00 hours), offering only a partial 
understanding of the variations over the 24 hours.27 28 
Therefore, in this study, the relationship of the CVD risk 
factors to time of day was explored using between-partic-
ipant variation only. In future studies, it may be advan-
tageous to carry out repeated measurement of the risk 
factors over the 24 hours in order to investigate with-
in-person circadian variations. However, with repeated 
measurements, a possible and genuine diurnal variation 
may be disrupted and natural sleeping patterns altered 
(repeated measures are usually taken every 1–2 hours 
during the night).29
implications
Variations of some CVD factors (in particular IL-6 and 
NT-proBNP) over the course of the day were observed, 
suggesting the role of time of the day as potential 
confounder during the measurements. However, 
standardising these biological markers by time of 
day was not particularly relevant for the cardiovas-
cular risk prediction. Also, other sensitivity analyses 
(stratified analysis and interaction tests) did not add 
relevant insights suggesting that time of day varia-
tions may be not important for clinical risk stratifica-
tion in general. Further studies assessing both CVD 
risk factors levels and clinical outcomes (eg, fatal or 
non-fatal CVD events) during 24 hours are required 
to demonstrate whether a rapid increase of IL-6 over 
the day may be relevant to the increased number of 
CVD events observed in early and late morning,30 and 
whether the increased levels of NT-proBNP over the 
day are related to the afternoon peak in sudden death 
following heart failure.31
cOnclusiOns
Variations in time of day were associated with varia-
tions of some, but not all, CVD risk factors measured in 
older adults. The contribution of time of the day to the 
markers’ overall variation was small and unlikely to affect 
the CVD risk prediction or clinical risk stratification.
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